McCairn KW, Iriki A, Isoda M. Common therapeutic mechanisms of pallidal deep brain stimulation for hypo-and hyperkinetic movement disorders. J Neurophysiol 114: 2090 -2104. First published July 15, 2015 doi:10.1152/jn.00223.2015.-Abnormalities in cortico-basal ganglia (CBG) networks can cause a variety of movement disorders ranging from hypokinetic disorders, such as Parkinson's disease (PD), to hyperkinetic conditions, such as Tourette syndrome (TS). Each condition is characterized by distinct patterns of abnormal neural discharge (dysrhythmia) at both the local single-neuron level and the global network level. Despite divergent etiologies, behavioral phenotypes, and neurophysiological profiles, high-frequency deep brain stimulation (HF-DBS) in the basal ganglia has been shown to be effective for both hypo-and hyperkinetic disorders. The aim of this review is to compare and contrast the electrophysiological hallmarks of PD and TS phenotypes in nonhuman primates and discuss why the same treatment (HF-DBS targeted to the globus pallidus internus, GPi-DBS) is capable of ameliorating both symptom profiles. Recent studies have shown that therapeutic GPi-DBS entrains the spiking of neurons located in the vicinity of the stimulating electrode, resulting in strong stimulus-locked modulations in firing probability with minimal changes in the population-scale firing rate. This stimulus effect normalizes/suppresses the pathological firing patterns and dysrhythmia that underlie specific phenotypes in both the PD and TS models. We propose that the elimination of pathological states via stimulus-driven entrainment and suppression, while maintaining thalamocortical network excitability within a normal physiological range, provides a common therapeutic mechanism through which HF-DBS permits information transfer for purposive motor behavior through the CBG while ameliorating conditions with widely different symptom profiles.
HIGH-FREQUENCY deep brain stimulation (HF-DBS) has emerged as a primary neurosurgical treatment for a number of neurological conditions refractory to drug therapy, especially for disorders arising from pathology within cortico-basal ganglia (CBG) networks. Generally, the disorders that arise from CBG abnormalities can be classified under the rubric of hypo-and hyperkinetic movement disorders. A representative example of a hypokinetic condition is Parkinson's disease (PD), while that of a hyperkinetic condition is Tourette syndrome (TS).
Historically, the most common use of HF-DBS-a procedure in which low-impedance macroelectrodes are chronically implanted into the basal ganglia to deliver high-frequency (ϳ150 Hz) electrical stimulation-has been for the amelioration of PD symptoms. Typically, the primary target for stimulation is the globus pallidus internus (GPi), the subthalamic nucleus (STN), or thalamus, with the STN being the most popular (Agid 1999; Benabid et al. 1987; Bronstein et al. 2011; Cooper et al. 1980; Krauss et al. 1999; Rodriguez-Oroz et al. 2005; Starr et al. 1998 Starr et al. , 2004 . More recently, encouraged by the success of HF-DBS in treating PD symptoms, there have been increasing attempts to apply the same procedure in basal ganglia-related hyperkinetic disorders such as TS and related tic disorders (Azoulay-Zyss et al. 2011; Dehning et al. 2008; Dueck et al. 2009; Houeto et al. 2005; Martinez-Fernandez et al. 2011; Martinez-Torres et al. 2009; Piedimonte et al. 2012; Shahed et al. 2007 ; van der Linden et al. 2002; Vandewalle et al. 1999; Welter et al. 2010) . Studies using animal models have confirmed clinical findings that HF-DBS can ameliorate symptoms of tic disorders (Angelov et al. 2014; Baup et al. 2008; McCairn et al. 2012 McCairn et al. , 2013b Posch et al. 2012) , leading to the consensus that HF-DBS can be an effective therapy for medically refractory TS (Schrock et al. 2015) . Thus clinical experience supports the therapeutic efficacy of HF-DBS for both hypo-and hyperkinetic disorders. However, the question remains of why the same intervention is effective against disease conditions that exhibit apparently opposing symptom profiles (i.e., hypokinetic vs. hyperkinetic) and divergent underlying pathophysiology.
To address this question, we here review the established literature for HF-DBS use in PD and parkinsonian models and compare the parallels in terms of effects and mechanisms of DBS actions with emerging data from stimulation-based therapies in TS and tic disorder models. In doing so, we place an emphasis on HF-DBS delivered to the GPi, the primary output nucleus for the basal ganglia skeletomotor circuit.
Hypokinetic Movement Disorder Pathophysiology: Parkinson's Disease
PD is a neurodegenerative condition that is associated with the accumulation of Lewy bodies and the loss of dopaminergic neurons in the midbrain and their innervation of CBG and forebrain structures (Braak et al. 2003; Kalia and Lang 2015) . There are a number of long-standing models with respect to functional changes within the CBG as a consequence of the underlying pathophysiology associated with PD, which can be extended to hyperkinetic disorders as well. Specifically, these models capture primary changes in the "indirect" and "direct" pathways, their effects on globus pallidus externus (GPe) and GPi, and the knock-on effects on thalamocortical networks, commonly referred to as the "box-and-arrow" models ( Fig. 1A ) (Albin et al. 1989; Alexander and Crutcher 1990; DeLong 1990) . Although several shortcomings have been pointed out as modern anatomical and physiological techniques paint a rather more complex picture, such as a disproportionate emphasis on tonic levels of activity, the incapability of predicting a role of oscillatory and synchronous activity, and a focus on unidirectional information flow through the network, the theoretical framework established by these models provides a useful starting point for discussing the latest findings related to hypo-and hyperkinetic movement disorders and the effects of DBS.
The pallidum is a heterogeneous structure consisting of a number of different cell types (Abdi et al. 2015 Fig. 1 . Representation of the intrinsic pathways of the basal ganglia. The schematic shows the "indirect" and "direct" pathways in the normal condition (black) and compares the relative strength (line thickness) and sign (inhibitory vs. excitatory) of the information flow as predicted by "box-and-arrow" models for hypokinetic/parkinsonism (red) and hyperkinetic/tourettism (green). Note the relative changes coming from the output nucleus of the basal ganglia [globus pallidus internus (GPi)] and the effects on motor cortical excitability. GPe, globus pallidus externus; STN, subthalamic nucleus. B: schematic illustrating how firing patterns, e.g., synchrony and oscillatory changes, are proposed to contribute to pathological behavior in hypo-and hyperkinetic disorders. In the normal GPi (top), neurons encoding physiological movement (white) transiently decrease activity, while surrounding neurons (black) maintain asynchronous firing patterns and normal levels of burstiness. In the parkinsonian condition (middle), there is an increase in lowfrequency oscillatory activity (indicated by sinusoids), synchronous spike-to-spike firing, and burstiness, with a reduction in neurons encoding for normal movement. With tourettism (bottom), there is a large increase in the number of neurons simultaneously encoding an extended action-release signal.
2015; Mastro et al. 2014; Nambu and Llinas 1997) . The GPe acts as a primary relay of the indirect pathway (Gerfen and Wilson 1996; Smith et al. 1998) , sending efferent projections to the STN (Francois et al. 2004; Mastro et al. 2014) , the GPi (Hazrati et al. 1990; Smith et al. 1994) , and the thalamic reticular nucleus (Hazrati and Parent 1991) as well as those back to the striatum (Beckstead 1983; Kita et al. 1999; Mastro et al. 2014) . In contrast, the GPi acts as the primary relay of the direct pathway, whose major target is the pallidal receiving regions of the thalamus (Albin et al. 1989 (Albin et al. , 1995 Baron et al. 2001; DeLong 1990; Parent and Parent 2004; Sidibe et al. 1997) . Although historically the internal pathways of the basal ganglia were conceptualized as being highly segregated, more recent studies have suggested that such a view should be treated with caution, with collateralization of striatofugal projections terminating in multiple targets in downstream nodes (Cazorla et al. 2014; Levesque and Parent 2005; Parent et al. 2000 Parent et al. , 2001 , while functional studies suggest that coactivation of both pathways is necessary for initiating movement (Cui et al. 2013 ; for review see Calabresi et al. 2014 ).
The firing properties of GP neurons, in a healthy brain, tend to show complex temporal patterns with both segments having high population-scale mean firing rates, e.g., ϳ70 Hz in the GPe vs. ϳ80 Hz in the GPi (DeLong 1971 (DeLong , 1972 Gardiner and Kitai 1992; Magill et al. 2000; Starr et al. 2005) . They also tend to show a low level or complete absence of any significant low-frequency oscillatory and correlated behavior between neighboring and distant neurons in the spectral and temporal domains (Bar-Gad et al. 2003; Bergman et al. 1998; Nini et al. 1995) . Functionally, the pallidal complex is perceived to initiate or modulate behavior by choosing one or more actions out of a multitude of actions presented to them by the corticostriatal network (Beiser and Houk 1998; Hikosaka 2007, 2008; Mink 1996; Redgrave et al. 1999; Tepper et al. 2004) . The encoding of behavioral parameters in pallidal activity is dependent on the context of the action, i.e., whether the task being performed is guided by sensory cues or memory or involves specific goal-directed and spatial/object characteristics (Arimura et al. 2013; Hoshi 2013; Jin et al. 2014; Turner and Anderson 2005) . It should be noted that pallidal processing is also modulated by inputs from the "hyperdirect" pathway that originates in the cortex and directly synapses within the STN (Chu et al. 2015; Mastro and Gittis 2015; Nambu et al. 2000 Nambu et al. , 2002 .
A long-held view on the pathophysiology of hypokinetic conditions in PD (e.g., akinesia) is that tonic firing rate changes occur at critical nodes in CBG network (Albin et al. 1989; DeLong 1990) . Specifically, the box-and-arrow model predicts that the absence of dopamine tips the balance between the two intrinsic pathways so that indirect pathway medium spiny neurons (MSNs) and direct pathway MSNs, respectively, increase and decrease their influence on the output nuclei of the basal ganglia. This imbalance leads to increased tonic inhibitory outflow from the GPi to the thalamus, which in turn reduces thalamocortical excitability (Fig. 1A) . There is indeed experimental evidence that supports this prediction (Pasquereau and Turner 2011; Starr et al. 2005) , while manipulation of the two pathways through optogenetic stimulation can induce or relieve parkinsonian symptoms (Kravitz et al. 2010 ).
The conceptual idea that changes in tonic firing rate can account for the symptoms associated with PD is attractive because of its simplicity-excessive inhibitory basal ganglia output leads to decreased cortical activity and thus decreased motor output. However, there are a number of other hypotheses as to why PD symptoms might develop. These emphasize spatiotemporal dynamics of cellular firing, including excessive oscillatory and synchronous activity in the alpha (7-12 Hz) and beta (13-30 Hz) frequency ranges commonly referred to as low-frequency oscillations (LFO), burst firing, and a breakdown of functional segregation in the CBG network (Filion and Tremblay 1991; Goldberg et al. 2002 Goldberg et al. , 2004 Hutchison et al. 1994 Hutchison et al. , 2004 Turner 2009, 2015; Pasquereau and Turner 2011; Raz et al. 2000; Soares et al. 2004; Stein and Bar-Gad 2013; Wichmann et al. 1999) (Fig. 1B) . Among the potential neuronal abnormalities, it is perhaps excessive LFO and synchronous activity in the temporal and spectral domain that have received most attention in recent years as the primary causal factor in the emergence of the antikinetic state in PD ( Fig. 2A) . Thus excessive synchrony and pathological LFO in the output nuclei of the basal ganglia are hypothesized to inhibit voluntary initiation of movement by exerting an impact on basal ganglia-recipient motor centers, such as cortical motor areas (Brown et al. 2004; Marsden et al. 2001b ).
Hyperkinetic Movement Disorder Pathophysiology: Tourette Syndrome
TS has been recognized as a discrete clinical condition for over a century (Gilles de la Tourette 1885). There are a number of key neurotransmitters that are hypothesized to play a role in the condition, including excess dopamine and decreased GABA (McCairn and Isoda 2013) . It is generally thought that TS involves focal abnormalities within the basal ganglia, particularly the striatum, that directly affect the indirect and direct pathways (Albin and Mink 2006; Israelashvili et al. 2015; McCairn et al. 2013a; Mink 2001 Mink , 2003 Peterson 2001) . Presumably, such abnormalities of the striatum arise as a consequence of dysfunctional GABAergic and cholinergic networks (Draper et al. 2014; Kalanithi et al. 2005; Kataoka et al. 2010; Lerner et al. 2012; Xu et al. 2015) because of a combination of complex genetic factors (Grados and Mathews 2008; Yu et al. 2015) . The spectrum of TS symptoms is wideranging; it includes motor, cognitive, and emotional abnormalities, suggesting that TS-related abnormalities affect all the functional territories (i.e., motor, associative, and limbic) of the CBG networks. Expressed behaviors range from simple motor tics and complex motor behaviors such as abnormal vocalization to neuropsychiatric abnormalities generally manifesting as obsessive-compulsive disorder (OCD) and attention-deficit/ hyperactivity disorder (ADHD) (The Tourette Syndrome Classification Study Group 1993).
In TS, the box-and-arrow model predicts that there should be a decrease in GPi output and excessive excitability in thalamocortical circuits for the expression of tics (Fig. 1 ). Direct recording from GPi neurons in human TS patients shows some evidence for decreased pallidal outflow (Alam et al. 2015; Zhuang et al. 2009 ) and excess LFO (Marceglia et al. 2010; Zauber et al. 2014) , indicating that both rate firing, as predicted by box-and-arrow models, and synchronous oscillatory activity contribute to the condition. Other studies using a nonhuman primate model of TS demonstrate persistent, periodic changes in activity within CBG networks (Bronfeld et al. 2011; Mc-Cairn et al. 2009 , 2013b Worbe et al. 2009 ) and cerebellar networks (McCairn et al. 2013c ) that phasically match predictions from classical box-and-arrow models. In these animal studies, the GABA antagonist bicuculline is microinjected into the motor territory of the putamen in order to induce periodic muscular contractions, recapitulating one of the primary symptoms of TS-simple myoclonic tics. Associated with these behaviors, periodic activations in EMG activity emerge that are driven by abnormal spiking activity in the striatum, pallidum, and related CBG structures (Fig. 2B) .
To summarize, although both PD and TS are complex neurological conditions, the emergence of differing symptom profiles can be envisaged to arise from abnormalities in basal ganglia processing. Specifically, within the striatum PD is thought to arise through a loss of DA innervation, while in TS excess influence from dopamine coupled with abnormalities in GABAergic transmission leads to uncontrolled movements and behaviors. These unwanted behaviors are primarily a result of imbalance between the indirect and direct pathways that originate from within the striatum and point to a critical role for the output nuclei of the basal ganglia and their effect on downstream networks.
Globus Pallidus Internus Deep Brain Stimulation
The premise for using stimulation-based therapies targeting the GPi stems from surprising observations that lesions intentionally made in the GPi, a neurosurgical procedure called pallidotomy, could ameliorate many of the symptoms associ- ated with PD (Meyers 1951) . Although pallidotomy as a treatment option has fallen in and out of favor several times (for review see Guridi and Lozano 1997) , it remains a practiced neurosurgical technique for the treatment of drug-refractory PD (Baron et al. 1996; Laitinen et al. 1992; Lozano et al. 1995) . However, because of its irreversibility, pallidotomy has been gradually superseded by stimulation-based therapies that target the same region.
Because of the similarity of the therapeutic responses between HF-DBS targeted to the GPi (GPi-DBS) and pallidotomy for PD-like movement disorders, early theories about the mechanism of action proposed that GPi-DBS works by inhibiting neuronal activity in the vicinity of the stimulating electrode, leading to the prevailing view that GPi-DBS is essentially a reversible, functional pallidotomy. This stimulation-induced inhibition of the GPi would reverse the pathological output from the basal ganglia, thereby normalizing activity in thalamocortical networks. There have been numerous clinical reports on the effectiveness of HF-DBS targeting the GPi for both PD (Bronstein et al. 2011; Rodriguez-Oroz et al. 2005) and TS (Ackermans et al. 2013; Schrock et al. 2015) . The efficacy of DBS has been shown to be dependent on a number of critical stimulation-related variables, including frequency, amplitude, polarity, pulse width, and pattern of stimulation (Birdno et al. 2012; Birdno and Grill 2008; Dorval et al. 2010; Kuncel et al. 2006; Rizzone et al. 2001) .
Critically, GPi-DBS has been shown to be effective for nonhuman primate models of PD (Fig. 3A) (Boraud et al. 1996; Johnson et al. 2012; McCairn and Turner 2009 ) and TS ( Fig.  3B) (McCairn et al. 2012 (McCairn et al. , 2013b . Therefore, it is possible to assess therapeutic correlates of pallidal single-unit responses during targeted stimulation in well-controlled animal test platforms. Direct measurement of the impact of GPi-DBS on firing rate changes shows that stimulation induces a number of response patterns in both PD and TS models (Fig. 4A) . In support of the general inhibition hypothesis, a subset of neurons respond with reductions in firing rates (Fig. 4B) while others can show near-complete inhibition (Fig. 4C) (Bar-Gad et al. 2004; Benazzouz et al. 1995; Boraud et al. 1996; Chiken and Nambu 2013; Dostrovsky et al. 2000; Erez et al. 2009; Liu et al. 2012; McCairn and Turner 2009; Wu et al. 2001) . These rate changes are probably not a product of depolarization block or voltage-gated current inactivation (Beurrier et al. 2001) , because it is possible to detect action potentials with no amplitude attenuation during a period of sustained reductions (McCairn and Turner 2009) . The observed inhibition is most likely due to stimulation-evoked GABA release (Chiken and Nambu 2013), as GABAergic afferents collateralize so extensively in both pallidal segments Sato et al. 2000a) .
However, in contrast to the prediction made by the inactivation hypothesis, it is commonly observed in monkeys that during GPi-DBS individual neurons in both segments of the pallidum show large and persistent increases in firing rate in PD (Agnesi et al. 2013; Bar-Gad et al. 2004; Erez et al. 2009; McCairn and Turner 2009 ) and TS models (Fig. 4, C and D ) (McCairn et al. 2012 (McCairn et al. , 2013b ). An interesting observation during delivery of GPi-DBS is that stimulus-driven cells can often show a decrementing waveform profile as stimulation progresses, as seen in the example from the TS model GPe waveform trace (Fig. 4A) . This effect is also reported in another study (Hashimoto et al. 2003; McCairn et al. 2012) . The mechanism for this amplitude reduction might be a form of partial depolarization blockade (Hollerman et al. 1992) , indicating that prolonged stimulation might drive the neuron to a point where the membrane properties can no longer respond to delivered pulses or synaptic input. The key point is that in both PD and TS models it is possible to find a mix of effects that include inhibition and excitation in both segments of the GP in response to GPi-DBS.
The observation of increased firing rates is consistent with the finding that neurons in the downstream efferent-recipient nuclei of the thalamus exhibit reduced firing rate (Anderson et al. 2003; Montgomery 2006) . In addition to direct electrophysiological evidence of HF-DBS driving individual pallidal neurons, experimental reports of changes in neurotransmitter concentrations (Stefani et Miocinovic et al. 2006 ). Therefore, inhibition is only a subcomponent of any therapeutic mechanism. It is also important to note that although GPi-DBS induces several distinct types of response at the level of individual pallidal neurons (Fig. 4) , the population-scale firing rate is virtually unchanged or only modestly affected during stimulation (Agnesi et al. 2013; Bar-Gad et al. 2004; Erez et al. 2009; McCairn et al. 2013b; McCairn and Turner 2009 ). This result is also replicated in PD patients receiving therapeutic levels of GPi-DBS (Cleary et al. 2013) . We posit that this maintenance of population-scale firing rates, at the output node of the basal ganglia, is a critical component of any therapeutic response. Maintenance of downstream network activity within a physiologically normal range preserves the ability of the network to continue to encode behaviorally relevant activity, a phenomenon that has recently been demonstrated in monkeys (Agnesi et al. 2013; Zimnik et al. 2015) .
A consistent feature of GPi-DBS is the induction of fast multiphasic changes in firing rate during interpulse intervals in both segments of the pallidum. The multiphasic responses can be broken down into discrete events: short-latency (Ͻ2 ms) phasic excitation in a manner consistent with antidromic driving, later-latency (3-5 ms) phasic excitation, and intervening periods of inhibition. These polyphasic responses are present in both PD (Fig. 5A) and TS ( The early-onset antidromic effects are clear in both disease conditions (McCairn et al. 2013b; McCairn and Turner 2009 ) and have been predicted by studies investigating the direct effects of electrical fields on neural tissue (Ranck 1975) as well as by modeling studies (McIntyre et al. 2004a (McIntyre et al. , 2004b . It has been demonstrated that direct activation of Na ϩ channels is the key ion channel mechanism for this fast-latency response ( most likely ascribed to the refractory period of the activated neurons. Other contributing factors to the intervening inhibition can include the activation of GABAergic afferents from the striatum (Hedreen and DeLong 1991; Parent et al. , 2000 Parent and Hazrati 1995) , those from the other pallidal segment (Chiken and Nambu 2013; Sato et al. 2000a) , and local axon collaterals. The later excitatory component of the multiphasic responses may be mediated by a variety of mechanisms and pathways. It could be a consequence of driving collateralized glutamatergic afferents from the STN (Moran et al. 2011; Sato et al. 2000b ), while postinhibition rebound may also be a contributing factor (Nambu and Llinas 1994) . In addition to these intrinsic basal ganglia pathways, extrinsic networks such as corticostriatal, corticosubthalamic, thalamostriatal (DeLong and Wichmann 2007) , and pontinepallidal (Gonya-Magee and Anderson 1983; Scarnati et al. 1988 ) pathways can also play a part. A modeling study of ion channel kinetics also suggests that an interplay between Na ϩ and K ϩ channels mediates much of the second excitatory phase within the interpulse period: that is, altering Na ϩ or K ϩ can lead to a tuning effect on the temporal dynamics of the later excitatory response (Johnson and McIntyre 2008) .
If entrainment constitutes a component of the therapeutic mechanism, is it possible to claim that even low-frequency stimulation could provide some beneficial clinical effects? Several studies have demonstrated that low-frequency stimulation at therapeutic amplitudes, or high-frequency stimulation at subtherapeutic amplitudes, can induce entrainment either locally or downstream from the stimulated nucleus; however, the entrainment tends not to be as pronounced as with therapeutic levels (Agnesi et al. 2013; Hashimoto et al. 2003; Johnson et al. 2009 ). Also, stimulation at lower frequencies, especially in the range of the oscillations associated with the disorder, can induce a worsening of clinical symptoms (Chen et al. 2007; Eusebio et al. 2008; Timmermann et al. 2004 ). Low-frequency stimulation also induces parkinsonian-like blink abnormalities in intact animals (Kaminer et al. 2014 ). Presumably, driving CBG networks that already overexpress oscillations in the pathological range merely exacerbates any impact these abnormal oscillations have on an already impaired system. Likewise, subtherapeutic-amplitude stimulation seems unlikely to affect individual neural elements enough to prevent propagation of abnormal signals through the network.
GPi-DBS-Mediated Suppression of Pathological Dysrhythmia
It is noteworthy that GPi-DBS induces similar single-unit responses in both PD and TS models despite their apparent differences in disease phenotype. Specifically, once stimulation is activated, a wave of neural excitation and inhibition occurs in rapid succession in both segments of the pallidum. This multiphasic response emerges in parallel with the cessation of the pathological activity characterizing each modeled disorder and the alleviation of behavioral symptoms. With respect to the PD model, GPi-DBS significantly suppresses excess LFO in both GPe and GPi, while inducing clinically measurable reductions in muscular rigidity (Fig. 6A ). This effect occurs along with the emergence of a high-frequency component in affected spike trains (Fig. 6B ) and the elimination of LFO synchrony (Fig. 6C ) (McCairn and Turner 2009 ). Similar effects have been observed with STN-DBS in parkinsonian monkeys (Meissner et al. 2005; Moran et al. 2012 ) and in dystonic hamsters (Leblois et al. 2010) . The suppression of oscillatory and synchronous activity is also observed in the primary motor cortex of monkeys (McCairn and Turner 2015) and rodents (Li et al. 2012 ) and has been inferred from studies in PD patients (Brown et al. 2004; Eusebio et al. 2011; Hammond et al. 2007; Marsden et al. 2001a) . With respect to the TS model, GPi-DBS is capable of suppressing the periodic, phasic activations in the GPe (Fig. 7A ) and phasic inhibitions in the GPi that drive tics ( 2013b). Therefore, the reduction/modulation of aberrant neural discharge occurs in both segments of the GP in both disease conditions. These findings suggest that GPi-DBS has a versatile mechanism for the elimination of abnormal network activity responsible for basal ganglia-mediated movement disorders, be their phenotype hypokinetic or hyperkinetic. An emerging consensus that takes into account the multitude of single-unit effects in models and patients posits that HF-DBS induces an "informational lesion" in CBG circuits. The premise behind this theory is that activity, both normal and pathological, is prevented from transmitting through basal ganglia output nodes because of the induction of regularized and suppressed firing patterns in stimulation-affected neurons, leading to reduced information-carrying capacity of spontaneous neuronal activity (Chiken and Nambu 2013; Dorval et al. 2008 Dorval et al. , 2010 Garcia et al. 2005; Grill et al. 2004; McIntyre and Hahn 2010; Rubin et al. 2012) . As a robust model of the network effects of HF-DBS, the "information lesion" hypothesis is dependent on observations of stimulation-entrained neuronal activity, especially in the output nuclei of the basal ganglia, being entirely composed of stimulation-mediated responses, be it entrainment or suppression. Recent studies have demonstrated, however, that during HF-DBS (targeting either GPi or STN) the GPi is still capable of encoding limbassociated movement kinematics (Agnesi et al. 2013; Zimnik et al. 2015) , albeit to a lesser extent, indicating that any information lesion, should it exist, is only partial or at least highly selective.
In light of the preservation of behaviorally relevant information while suppressing unwanted pathological dysrhythmia, it would appear that HF-DBS can be thought of more as an "information filter," as has been posited very recently (Rosenbaum et al. 2014; Zimnik et al. 2015) , that disrupts abnormal information flow (Chiken and Nambu 2015; Israelashvili et al. 2015) . This filtering/disrupting property operates through multiple mechanisms; however, we propose that these mechanisms, i.e., entrainment and suppression, are dependent on the maintenance of thalamocortical activity within a normal physiological range, as indicated by minimal changes in populationscale firing rates in basal ganglia output nuclei and downstream recipient regions. One can consider in the case of suppression/ inhibition, that if GPi neurons are tonically suppressed they would be no longer capable of relaying pathological discharge originating from the striatum to their efferent targets. However, such a continuous suppression of GPi neurons would then release, via disinhibition, miscellaneous cortically issued motor programs that may interfere with ongoing purposive motor behavior. One can also consider that if GPi neurons are forcibly excited at the unusually high firing rate via entrainment with DBS pulses, they are again incapable of transmitting aberrant incoming signals to their efferent targets. However, such a continuous excitation of GPi neurons would then nonselectively inhibit cortically driven motor programs that are necessary to control purposive motor behavior. We conjecture that stimulation frequency-dependent entrainment and suppression, in parallel with a negligible impact on the populationscale firing rate, while maintaining the ability to continuously encode normal behavior in the context of relatively normal thalamocortical excitability, is an ideal condition to both achieve therapeutic effects and minimize adverse effects (Fig.  8) . That is, the conduction of low-frequency pathological signals would be blocked in the pallidum by the high-frequency, periodic alternation of excitation and inhibition, thereby successfully eliminating aberrant discharge in basal ganglia-recipient networks. The minimal effect on the population-averaged firing rate would allow for the maintenance of the basal ganglia output tone within the physiological range, whereby cortical motor areas can properly issue necessary motor programs to subcortical structures such as the brain stem and spinal cord.
Conclusions
In summary, the effects of GPi-DBS on pallidal singleneuron activity are surprisingly similar between hypokinetic Increased inhibitory tone Decreased excitatory tone Fig. 8 . GPi-DBS mechanism of action. Schematic illustration of a proposed mechanism of action for GPi-DBS. Top: pallidal outflow, when corrupted by synchronous, low-frequency pathological dysrhythmia, leads to hypo-or hyperkinetic condition that is underlined by abnormal thalamocortical excitability. Line thickness represents relative weight of inhibitory/excitatory output from each node. Bottom: GPi-DBS, through stimulation-driven entrainment, induces a high-pass, low-cut filter in basal ganglia output (GPi), followed by an induction of least pathological encoding in GPi-thalamic pathways, leading to a normalization of thalamocortical excitability and a maintenance of functional kinematic encoding for normal behavior. MCx, motor cortex.
and hyperkinetic movement disorders. HF-DBS induces complex patterns of excitation and inhibition, and this multiphasic response is capable of suppressing abnormal dysrhythmia and synchrony in PD models, while the same effect normalizes the pathological phasic discharge that drives motor tics and, presumably, excess LFO as well in TS models. Importantly, such multiphasic responses have minimal effects on the populationscale mean firing rate of pallidal neurons. We propose that GPi-DBS-mediated activity in basal ganglia output instantiates a high-pass/low-cut filter with respect to ongoing pathological activity. Thus GPi-DBS can minimize deleterious low-frequency reverberations in downstream networks, while artificially inducing a "least pathological encoding" that permits task-related information flow through the maintenance of thalamocortical excitability. GPi-DBS has been proven to be effective in both PD and TS. With the continuing use of basic research in model systems, we hope that future research will continue to refine and improve the clinical effectiveness of this vital surgical treatment.
